• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism

ABPI_Incentivising_Antibioics_peter-pryharski-unsplash_landscape
Read more

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 29th May 2018

OHE at HTAi 2018

Meet some of the OHE team at the Health Technology Assessment International (HTAi) 2018 conference in Vancouver, 1-5 June. Meet some of the OHE team at the Health Technology Assessment International (HTAi) 2018 conference in Vancouver, 1-5 June. Later this…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

Meet some of the OHE team at the Health Technology Assessment International (HTAi) 2018 conference in Vancouver, 1-5 June.

Meet some of the OHE team at the Health Technology Assessment International (HTAi) 2018 conference in Vancouver, 1-5 June.

Later this week, Adrian Towse, Koonal Shah, Grace Hampson, and Chris Sampson will be travelling to Vancouver, Canada, to participate in HTAi 2018 and to present some of OHE’s ongoing work. The theme for this year’s conference is Strengthening the Evidence-to-Action Connection. You can meet the team at the following sessions.

Panel: How Should We Value and Pay for New Antibiotics?

[Sunday, 10:45 AM – 12:00 PM, Cypress 1 (Level 2)]

This session will explore how the benefits of antibiotics can best be captured in HTA, and how we should pay for them when their value may depend on restricting their use. Adrian Towse, Chris Henshall, Taimur Bhatti, Judith Glennie, and Monika Schneider will be panellists.

Sponsored Symposium: Clinical, Organizational and Policy Opportunities to Tackle In-Hospital Surge of AMR

[Sunday, 12:15 PM – 1:45 PM, Cypress 2 (Level 2)]

Hospitals and intensive care units are recognised as ground for the possible development of antimicrobial resistance (AMR) and hospital-acquired infections (HAIs). Adrian Towse, Americo Cicchetti, Iñaki Gutiérrez-Ibarluzea, Roman Kozlov, Adrian Pana, and Davide Croce will explore potential initiatives in this symposium sponsored by Angelini.

Oral Presentation: Optimizing the use of RWE in HTA: Lessons From the ICER Summit

[Sunday, 2:00 PM – 4:00 PM, Salon 1 (Level 2)]

Grace Hampson will present recommendations on the roles that stakeholder groups can play in overcoming challenges associated with using real-world evidence.

Oral Presentation: Optimising Risk-Based Screening: The Case of Diabetic Eye Disease

[Sunday, 2:00 PM – 4:00 PM, Salon E (Level 1)]

In this presentation, Chris Sampson will describe the development of a decision model used to evaluate the cost-effectiveness of risk-based screening for diabetic retinopathy, and explore the potential for individualised cost-effectiveness analysis.

Poster: Long-Term Evaluation of Broad Mental Health Interventions: A Review

[Sunday, 4:00 PM – 4:30 PM, Presentation Column 11 (Level 1)]

Chris Sampson will discuss the challenges and barriers to research in the context of broad mental health interventions and make recommendations for future strategies.

Panel: From Evidence to Action When People Disagree: Societal Values and Provision of End of Life Medicines

[Monday, 11:15 AM – 12:30 PM, Oak 2 (Level 2)]

Koonal Shah will join Rachel Baker and Ailsa Brown on this panel to reflect on empirical findings and raise questions for evidence-based policy on the provision of end of life medicines.

Vignette: Developing a Value Set for the EQ-5D-Y to Support its Use in HTA

[Monday, 2:30 PM – 3:15 PM, Salon D (Level 1)]

In this presentation, Koonal Shah will summarise the challenges and ongoing work in the development of a value set for the EQ-5D-Y in the UK.

Panel: Multi-stakeholder Dialogues Addressing Needs, HTA Requirements and Good Practices in Emerging Countries

[Monday, 3:30 PM – 4:45 PM, Oak 2 (Level 2)]

Adrian Towse will join this panel with Alicia Granados, Sarah Garner, and Andre Rivire to explore the impact and actions emerging from international discussions about the role of HTA.

Panel: Building Bridges Not Walls: Can We Develop Sustainable and Sharable Cost-Effectiveness Models?

[Monday, 3:30 PM – 4:45 PM, Salon D (Level 1)]

Chris Sampson, Deborah Marshall, Stirling Bryan, and Steven Pearson will explore and identify opportunities, barriers, and future strategies for developing and implementing key infrastructure to support collaborative and transparent cost-effectiveness models.

 

In addition to the team’s own presentations, OHE staff have contributed to other items on the programme, which will be presented by our collaborators:

  • Poster: Issues on the Estimation of the Opportunity Cost Threshold Value
    [Monday, 1:45 PM – 2:15 PM, Presentation Column 06 (Level 1)]
  • Oral Presentation: Expanding Cost-Effectiveness Analysis: Measures and Methods
    [Tuesday, 8:00 AM – 9:00 AM, Salon 1 (Level 2)]

 

  • Health Technology Assessment…
  • Measuring and Valuing Outcomes

Related News

IRA-course-graphic-for-website-news-FINAL-1
  • News
  • May 2023

New free educational program launched – Explaining the U.S. Inflation Reduction Act

Read more
Group 11119
  • News
  • February 2023

Applications open for MSc Fellowship Programme 2023

Read more
Prize event
  • News
  • January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Read more
  • News
  • July 2022

OHE is Leading Research to Develop an EQ-5D ‘Bolt-on’ for Hearing

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!